STAT3 and hepatocellular carcinoma: Looking at the directional effect of LDHC silencing, we found that reducing LDHC expression inhibited the STAT3 pathway and promoted the GP6 signaling pathway in both basal-like cell lines in contrast to the HCC-1954 cell line (Figure 2D—right).